
Part 1: Complexities in Data Collection Blog Post
In this video interview with ACT editor Andy Studna, Erin Erginer, director of product, Certara highlights challenges with data volume and complexity.
In this video interview with ACT editor Andy Studna, Erin Erginer, director of product, Certara highlights challenges with data volume and complexity.
连接癌症与自身免疫;“从疗效或安全性的角度来看,肿瘤学中的给药方案可能无法直接为自身免疫性疾病的最佳选择提供参考”。The level of immune activation…
Background Monkeys and humans share a strong bond, reflected not only in a shared genetic heritage, but in history and folklore. In Chinese literature from the 16th century, Journey to the…
In this podcast, Dr. Chris Bouton, Senior VP and Head of AI at Certara, highlights how generative AI is being applied to increase the efficiency of drug discovery and development….
The article titled “Using PBPK modeling to supplement clinical data and support the safe and effective use of dolutegravir in pregnant and lactating women,” authored by Jia Ning, Amita Pansari,…
Discover the 6 dos and don’ts of creating compliant define.xml files for FDA submission with our free, downloadable Define-XML format guide.
了解如何根据 CDISC 数据标准轻松管理和验证我们的 CDISC 标准管理完整指南。
RADNOR, PA – 2024 年 10 月 30 日 – Certara, Inc. (纳斯达克股票代码:CERT), a global leader in model-informed drug development, today announced the appointment of Dr. Tong Zhu, FCP, to lead its…
摘要:T cell interaction in the tumor microenvironment is a key component of immuno-oncology therapy. Glucocorticoid-induced tumor necrosis factor receptor (TNFR)-related protein (GITR) is expressed on immune cells including regulatory…